Adjustment to the rights of the holders of convertible bonds

Liege, Belgium, 02 September 2022 - 17:45 CET - Mithra Pharmaceuticals SA (Euronext Brussels: MITRA), a company dedicated to Women's Health, announces today that, as a result of the senior secured convertible facilities agreement and conversion agreement entered into by the Company and announced on 8 August 2022, and in accordance with condition 5(b) of the Company's EUR 125,000,000 senior unsecured convertible bonds due 2025 (ISIN: BE6325746855), the conversion price of the bonds has been adjusted from EUR 25.1917 to EUR 24.5425, effective as of 8 August 2022.